FrancophonIA/DGT-Translation_Memory huggingface dataset:
English: , The local lymph node assay: A viable alternative to currently accepted skin sensitisation tests, Food Chem.
Portuguese: The local lymph node assay: A viable alternative to currently accepted skin sensitisation tests. Food Chem.
Finnish: The local lymph node assay: A viable alternative to currently accepted skin sensitisation tests. Food Chem. Toxicol.
Czech: , The local lymph node a. s.say: A viable alternative to currently accepted skin sensitisation tests, Food Chem.
English: Toxicol., 34, 985-997.
Swedish: Toxicol., 34, 985–997.
Finnish: 34, s. 985–997.
Czech: Toxicol., 34, 985–997.
Slovak: Food Chem. Toxicol., 34, 985 – 997.
Polish: Toxicol., 34, 985–997.
Slovenian: Toxicol., 34, 985–997.
Estonian: Toxicol., 34, 985–997.
Lithuanian: Food Chem. Toxicol., 34, 985–997.
Maltese: Toxicol., 34, 985–997.
English: Toxicol., 36, 327-33.
Swedish: Toxicol., 36, 327–33.
Finnish: 36, s. 327–33.
Czech: Toxicol., 36, 327–33.
Slovak: Food Chem. Toxicol., 36, 327 – 333.
Polish: Toxicol., 36, 327–33.
Slovenian: Toxicol., 36, 327–33.
Estonian: Toxicol., 36, 327–33.
Lithuanian: Food Chem. Toxicol., 36, 327–33.
Maltese: Toxicol., 36, 327–33.
English: , ICCVAM evaluation of the murine local lymph node assay: II.
Portuguese: ICCVAM evaluation of the murine local lymph node assay: II.
Dutch: , ICCVAM evaluation of the murine local lymph node assay: II. Conclusions and recommendations of an independent scientific peer review panel, Reg.
Finnish: ICCVAM evaluation of the murine local lymph node assay: II.
Czech: , ICCVAM evaluation of the murine local lymph node a. s.say: II.
Slovak: S. (2001), ICCVAM evaluation of the murine local lymph node assay: II.
English: Pharmacol, 34: 258-273.
French: Pharmacol, 34(3): 258-273.
Portuguese: Pharmacol., 34, 258-273.
Swedish: Pharmacol, 34: 258–273.
Finnish: Pharmacol 34, s. 258–273.
Czech: Pharmacol, 34: 258–273.
Slovak: Pharmaco., 34, 258 – 273.
Polish: Pharmacol, 34: 258–273.
Slovenian: Pharmacol, 34: 258–273.
Estonian: Pharmacol, 34: 258–273.
Lithuanian: Pharmacol, 34: 258–273.
Maltese: Pharmacol, 34: 258–273.
English: , ICCVAM evaluation of the murine local lymph node assay: III.
Portuguese: ICCVAM evaluation of the murine local lymph node assay: III.
Dutch: , ICCVAM evaluation of the murine local lymph node assay: III. Data analyses completed by the national toxicology program interagency center for the evaluation of alternative toxicological methods, Reg.
Finnish: ICCVAM evaluation of the murine local lymph node assay: III.
Czech: , ICCVAM evaluation of the murine local lymph node a. s.say: III.
Slovak: S. (2001), ICCVAM evaluation of the murine local lymph node assay: III.
English: Pharmacol, 34, 274-286.
French: Pharmacol, 34(3), 274-286.
Portuguese: Pharmacol., 34, 274-286.
Swedish: Pharmacol, 34, 274–286.
Finnish: Pharmacol 34, s. 274–286.
Czech: Pharmacol, 34, 274–286.
Slovak: Pharmaco., 34, 274 – 286.
Polish: Pharmacol, 34, 274–286.
Slovenian: Pharmacol, 34, 274–286.
Estonian: Pharmacol, 34, 274–286.
Lithuanian: Pharmacol, 34, 274–286.
Maltese: Pharmacol, 34, 274–286.
English: , ICCVAM evaluation of the murine local lymph node assay: I. The ICCVAM review process, Reg. Toxicol.
Portuguese: ICCVAM evaluation of the murine local lymph node assay: I. The ICCVAM review process. Reg. Toxicol.
Finnish: ICCVAM evaluation of the murine local lymph node assay: I. The ICCVAM review process. Reg. Toxicol.
Czech: , ICCVAM evaluation of the murine local lymph node a. s.say: I. The ICCVAM review process, Reg. Toxicol.
Slovak: S. (2001), ICCVAM evaluation of the murine local lymph node assay: I. The ICCVAM review process, Reg. Toxicol.
English: Pharmacol, 34: 249-257.
French: Pharmacol, 34(3): 249-257.
Portuguese: Pharmacol., 34, 249-257.
Swedish: Pharmacol, 34: 249–257.
Finnish: Pharmacol 34, s. 249–257.
Czech: Pharmacol, 34: 249–257.
Slovak: Pharmaco., 34, 249 – 257.
Polish: Pharmacol, 34: 249–257.
Slovenian: Pharmacol, 34: 249–257.
Estonian: Pharmacol, 34: 249–257.
Lithuanian: Pharmacol, 34: 249–257.
Maltese: Pharmacol, 34: 249–257.
English: Toxicol., 18, 281-284.
Swedish: Toxicol., 18, 281–284.
Finnish: 18, s. 281–284.
Czech: Toxicol., 18, 281–284.
Slovak: Toxicol., 18, 281 – 284.
Polish: Toxicol., 18, 281–284.
Slovenian: Toxicol., 18, 281–284.
Estonian: Toxicol., 18, 281–284.
Lithuanian: Toxicol., 18, 281–284.
Maltese: Toxicol., 18, 281–284.
English: Contact Dermatitis, 54, 181-185.
Swedish: Contact Dermatitis, 54, 181–185.
Finnish: Contact Dermatitis 54, s. 181–185.
Greek: a cut-down screen to reduce animal requirements? Contact Dermatitis, 54, 181-185.
Czech: Contact Dermatitis, 54, 181–185.
Slovak: Contact Dermatitis, 54, 181 – 185.
Polish: Contact Dermatitis, 54, 181–185.
Slovenian: Contact Dermatitis, 54, 181–185.
Estonian: Contact Dermatitis, 54, 181–185.
Lithuanian: Contact Dermatitis, 54, 181–185.
Maltese: Contact Dermatitis, 54, 181–185.
English: Toxicol., 46, 1896-1904.
Swedish: Toxicol., 46, 1896–1904.
Finnish: 46, s. 1896–1904.
Czech: Toxicol., 46, 1896–1904.
Slovak: Food Chem. Toxicol., 46, 1896 – 1904.
Polish: Toxicol., 46, 1896–1904.
Slovenian: Toxicol., 46, 1896–1904.
Estonian: Toxicol., 46, 1896–1904.
Lithuanian: Food Chem. Toxicol., 46, 1896–1904.
Maltese: Toxicol., 46, 1896–1904.
English: Pharmacol., 55, 90-96.
French: Toxicol.Pharmacol., 55, 90-96.
Swedish: Pharmacol., 55, 90–96.
Finnish: Pharmacol 55, s. 90–96.
Czech: Pharmacol., 55, 90–96.
Slovak: Pharmacol., 55, 90 – 96.
Polish: Pharmacol., 55, 90–96.
Slovenian: Pharmacol., 55, 90–96.
Estonian: Pharmacol., 55, 90–96.
Lithuanian: Pharmacol., 55, 90–96.
Maltese: Pharmacol., 55, 90–96.
English: , The murine local lymph node assay: regulatory and potency considerations under REACH, Toxicol., 238, 71-89.
Portuguese: The murine local lymph node assay: regulatory and potency considerations under REACH. Toxicol., 238, 71-89.
Swedish: , The murine local lymph node assay: regulatory and potency considerations under REACH, Toxicol., 238, 71–89.
Finnish: 238, s. 71–89.
Czech: , The murine local lymph node assay: regulatory and potency considerations under REACH, Toxicol., 238, 71–89.
Polish: , The murine local lymph node assay: regulatory and potency considerations under REACH, Toxicol., 238, 71–89.
Slovenian: , The murine local lymph node assay: regulatory and potency considerations under REACH, Toxicol., 238, 71–89.
Estonian: , The murine local lymph node assay: regulatory and potency considerations under REACH, Toxicol., 238, 71–89.
Lithuanian: , The murine local lymph node assay: regulatory and potency considerations under REACH, Toxicol., 238, 71–89.
Maltese: , The murine local lymph node assay: regulatory and potency considerations under REACH, Toxicol., 238, 71–89.
English: OECD (2002), Acute Dermal Irritation/Corrosion.
Spanish: OCDE (2002), Acute Dermal Irritation/Corrosion.
Italian: OCSE (2002), Acute Dermal Irritation/Corrosion. OCSE Guideline for Testing of Chemicals No.
Portuguese: OCDE (2002). Acute Dermal Irritation/Corrosion.
Dutch: OECD (2002), Acute Dermal Irritation/Corrosion. OECD Guideline for Testing of Chemicals No.
Swedish: OECD (2002), Acute Dermal Irritation/Corrosion. OECD Guideline for Testing of Chemicals No.
Finnish: OECD (2002). Acute Dermal Irritation/Corrosion.
Greek: OECD (2002), Acute Dermal Irritation/Corrosion. OECD Guideline for Testing of Chemicals No.
Czech: OECD (2002), Acute Dermal Irritation/Corrosion. OECD Guideline for Testing of Chemicals No.
Slovak: OECD (2002), Acute Dermal Irritation/Corrosion.
Polish: OECD (2002), Acute Dermal Irritation/Corrosion. OECD Guideline for Testing of Chemicals No.
Hungarian: OECD (2002), Acute Dermal Irritation/Corrosion. OECD Guideline for Testing of Chemicals No.
Slovenian: OECD (2002), Acute Dermal Irritation/Corrosion. OECD Guideline for Testing of Chemicals No.
Estonian: OECD (2002), Acute Dermal Irritation/Corrosion. OECD Guideline for Testing of Chemicals No.
Latvian: OECD (2002), Acute Dermal Irritation/Corrosion. OECD Guideline for Testing of Chemicals No.
Lithuanian: OECD (2002), Acute Dermal Irritation/Corrosion. OECD Guideline for Testing of Chemicals No.
Maltese: OECD (2002), Acute Dermal Irritation/Corrosion. OECD Guideline for Testing of Chemicals No.
English: Toxicol., 21, 195-206.
Swedish: Toxicol., 21, 195–206.
Finnish: 21, s. 195–206.
Czech: Toxicol., 21, 195–206.
Slovak: Drug Chem. Toxicol., 21, 195 – 206.
Polish: Toxicol., 21, 195–206.
Slovenian: Toxicol., 21, 195–206.
Estonian: Toxicol., 21, 195–206.
Lithuanian: Drug Chem. Toxicol., 21, 195–206.
Maltese: Toxicol., 21, 195–206.
English: Pharmacol., 153, 83-94.
Swedish: Pharmacol., 153, 83–94.
Finnish: 153, s. 83–94.
Czech: Pharmacol., 153, 83–94.
Slovak: Pharmacol., 153, 83 – 94.
Polish: Pharmacol., 153, 83–94.
Slovenian: Pharmacol., 153, 83–94.
Estonian: Pharmacol., 153, 83–94.
Lithuanian: Pharmacol., 153, 83–94.
Maltese: Pharmacol., 153, 83–94.
English: Meth., 8, 245-256.
Swedish: Meth., 8, 245–256.
Finnish: 8, s. 245–256.
Czech: Meth., 8, 245–256.
Slovak: Meth., 8, 245 – 256.
Polish: Meth., 8, 245–256.
Slovenian: Meth., 8, 245–256.
Estonian: Meth., 8, 245–256.
Lithuanian: Meth., 8, 245–256.
Maltese: Meth., 8, 245–256.
English: Toxicol., 22, 491-506.
Swedish: Toxicol., 22, 491–506.
Finnish: 22, s. 491–506.
Czech: Toxicol., 22, 491–506.
Slovak: Chem. Toxicol., 22, 491 – 506.
Polish: Toxicol., 22, 491–506.
Slovenian: Toxicol., 22, 491–506.
Estonian: Toxicol., 22, 491–506.
Lithuanian: Chem. Toxicol., 22, 491–506.
Maltese: Toxicol., 22, 491–506.
English: Toxicol., 212, 60-68.
Swedish: Toxicol., 212, 60–68.
Finnish: 212, s. 60–68.
Czech: Toxicol., 212, 60–68.
Slovak: Toxicol., 212, 60 – 68.
Polish: Toxicol., 212, 60–68.
Slovenian: Toxicol., 212, 60–68.
Estonian: Toxicol., 212, 60–68.
Lithuanian: Toxicol., 212, 60–68.
Maltese: Toxicol., 212, 60–68.
English: Toxicol., 79, 721-728.
Swedish: Toxicol., 79, 721–728.
Finnish: 79, s. 721–728.
Czech: Toxicol., 79, 721–728.
Slovak: Toxicol., 79, 721 – 728.
Polish: Toxicol., 79, 721–728.
Slovenian: Toxicol., 79, 721–728.
Estonian: Toxicol., 79, 721–728.
Lithuanian: Toxicol., 79, 721–728.
Maltese: Toxicol., 79, 721–728.
English: Health Perspect., 115, 1023-1028.
Swedish: Health Perspect., 115, 1023–1028.
Finnish: 115, s. 1023–1028.
Czech: Health Perspect., 115, 1023–1028.
Slovak: Health Perspect., 115, 1023 – 1028.
Polish: Health Perspect., 115, 1023–1028.
Slovenian: Health Perspect., 115, 1023–1028.
Lithuanian: Health Perspect., 115, 1023–1028.
Maltese: Health Perspect., 115, 1023–1028.
English: (1 % Triton X-100) (27)
Spanish: (tritón X-100 al 1 %) (27)
Italian: (1 % Triton X-100)(27)
Portuguese: (Triton X-100 a 1 %)(27)
Czech: (1 % Triton X-100)(27)
Polish: (1 % Triton X-100)(27)
Hungarian: (1 % Triton X-100)(27)
Slovenian: dstotni Triton X-100) (27)
Latvian: (1 % Triton X-100)(27)
Lithuanian: (1 % „Triton X-100“)(27)
English: (1 % Triton X-100) (28)
Spanish: (tritón X-100 al 1 %) (28)
Italian: (1 % Triton X-100)(28)
Portuguese: (Triton X-100 a 1 %)(28)
Czech: (1 % Triton X-100)(28)
Polish: (1 % Triton X-100)(28)
Hungarian: (1 % Triton X-100)(28)
Slovenian: dstotni Triton X-100) (28)
Latvian: (1 % Triton X-100)(28)
Lithuanian: (1 % „Triton X-100“)(28)
English: Complete supporting information for the specific RhE model used including its performance.
German: umfassende Begleitdokumentation für das betreffende Hautmodell, einschließlich seiner Leistung.
Italian: informazioni complete sul modello di epidermide specifico utilizzato e sulla sua efficienza.
Dutch: volledige ondersteunende informatie over het specifieke gebruikte huidmodel, met inbegrip van de deugdelijkheid daarvan.
Danish: komplet dokumentation for den anvendte RhE-model, herunder om dens ydeevne.
Swedish: Fullständig stödjande information för den specifika RhE-modell som använts, inklusive modellens prestanda.
Finnish: täydelliset RhE-mallin käyttöä tukevat tiedot (mukaan luettuna mallin suoritusarvot).
Greek: πλήρη στοιχεία τεκμηρίωσης για το συγκεκριμένο μοντέλο RhE που χρησιμοποιήθηκε, συμπεριλαμβανομένων των επιδόσεών του.
Czech: úplné podklady ke konkrétnímu použitému modelu rekonstruované lidské epidermis včetně jeho chování při zkoušce.
Slovak: úplné podporné údaje o použitom osobitnom modeli RhE vrátane jeho výkonnosti.
Polish: pełne informacje podstawowe na temat stosowanego modelu RhE, z uwzględnieniem jego efektywności.
Hungarian: az alkalmazott specifikus RhE-modellre vonatkozó teljes körű alátámasztó adatok, köztük a modell teljesítménye.
Slovenian: popolne informacije za podporo specifičnemu uporabljenemu modelu rekonstruirane človeške pokožnice, vključno z njegovo učinkovitostjo.
Romanian: informații complete privind modelul de RhE utilizat, inclusiv performanța acestuia.
Estonian: kogu täiendav teave kasutatud konkreetse RhE-mudeli ja selle tulemuslikkuse kohta.
Latvian: pietiekama papildinformācija par izmantoto RhE modeli un tā veiktspējas raksturlielumiem.
Lithuanian: visa su konkrečiu RhE modeliu susijusi informacija, įskaitant jo naudojimo charakteristikas.
Maltese: Informazzjoni ta’ appoġġ kompluta għall-mudell tal-RhE speċifiku użat inkluża l-prestazzjoni tiegħu.
English: This should include, but is not limited to;
German: Diese sollte unter anderem die folgenden Aspekte beinhalten:
Italian: Esse dovrebbero includere (elenco non esauriente):
Dutch: Hieronder moet ten minste informatie zijn over:
Danish: Der skal bl.a. gives oplysning om:
Swedish: Informationen ska omfatta men inte vara begränsad till följande:
Finnish: Näitä voivat olla, luettelon olematta tyhjentävä,
Greek: Τα εν λόγω στοιχεία πρέπει να περιλαμβάνουν τα ακόλουθα, χωρίς να περιορίζονται σ’ αυτά:
Czech: Ty by měly zejména zahrnovat:
Slovak: K nim by mala patriť predovšetkým:
Polish: Powinno to w szczególności obejmować:
Hungarian: Ennek többek között az alábbiakat kell magában foglalnia:
Slovenian: To lahko vključuje, vendar ni omejeno na:
Romanian: Aceasta trebuie să includă (listă neexhaustivă):
Estonian: See hõlmab vähemalt järgmist:
Latvian: No tiem jānorāda vismaz:
Lithuanian: Ją turi sudaryti šie ir kiti duomenys:
Maltese: Din l-informazzjoni għandha tiġi inkluża, iżda ma għandhiex tkun limitata għal dawn:
English: Reference to historical data of the model.
German: Verweis auf historische Modelldaten.
Italian: riferimenti a dati storici del modello.
Dutch: verwijzingen naar historische gegevens over het model.
Danish: reference til historiske data for modellen.
Swedish: Hänvisning till historiska uppgifter om modellen.
Finnish: viittaukset mallia koskeviin aiempiin tietoihin.
Greek: παραπομπή σε ιστορικά δεδομένα για το μοντέλο.
Czech: odkaz na dosavadní údaje modelu.
Slovak: odkaz na historické údaje o modeli.
Polish: odwołanie do danych historycznych modelu.
Hungarian: hivatkozás a modellel kapott korábbi adatokra.
Slovenian: sklicevanje na podatke o modelu, pridobljene v preteklosti.
Romanian: trimiteri la datele istorice ale modelului.
Estonian: viide varasematele andmetele mudeli kohta.
Latvian: vēsturiskie dati par modeli.
Lithuanian: nuoroda į anksčiau sukauptus modelio duomenis.
Maltese: Referenza għad-dejta storika tal-mudell.
English: This should include, but is not limited to:
German: Diese sollte unter anderem die folgenden Aspekte beinhalten:
Italian: Essi dovrebbero includere (elenco non esauriente):
Dutch: Deze moeten ten minste omvatten:
Danish: Der skal bl.a. gives oplysning om:
Swedish: Dessa ska omfatta men inte vara begränsade till följande:
Finnish: Näitä voivat olla, luettelon olematta tyhjentävä,
Greek: Τα εν λόγω δεδομένα πρέπει να περιλαμβάνουν τα ακόλουθα, χωρίς να περιορίζονται σ’ αυτά:
Czech: Ty by měly zejména zahrnovat:
Slovak: K nim by mali patriť predovšetkým:
Polish: Powinno to między innymi obejmować:
Hungarian: Ennek többek között az alábbiakat kell magában foglalnia:
Slovenian: To lahko vključuje, vendar ni omejeno na:
Romanian: Aceasta trebuie să includă (listă neexhaustivă):
Estonian: See hõlmab vähemalt järgmist:
Latvian: No tiem jānorāda vismaz:
Lithuanian: Ją turi sudaryti šie ir kiti duomenys:
Maltese: Din għandha tinkludi, iżda ma għandhiex tkun limitata għal:
English: M. and Botham, P. (2001), A prevalidation study on in vitro tests for acute skin irritation, Results and evaluation by the Management Team, Toxicol. in Vitro 15, 57-93.
French: Results and evaluation by the Management Team, Toxicol. in Vitro 15, 57-93.
Portuguese: M., Botham, P. (2001). A prevalidation study on in vitro tests for acute skin irritation, Results and evaluation by the Management Team. Toxicol. in Vitro, 15, 57-93.
Swedish: M. och Botham, P. (2001), A prevalidation study on in vitro tests for acute skin irritation, Results and evaluation by the Management Team, Toxicol. in Vitro 15, 57–93.
Finnish: Toxicol. in Vitro 15, s. 57–93.
Czech: M. and Botham, P. (2001), A prevalidation study on in vitro tests for acute skin irritation, Results and evaluation by the Management Team, Toxicol. in Vitro 15, 57–93.
Polish: M. and Botham, P. (2001), A prevalidation study on in vitro tests for acute skin irritation, Results and evaluation by the Management Team, Toxicol. in Vitro 15, 57–93.
Slovenian: M. and Botham, P. (2001), A prevalidation study on in vitro tests for acute skin irritation, Results and evaluation by the Management Team, Toxicol. in Vitro 15, 57–93.
Estonian: M. and Botham, P. (2001), A prevalidation study on in vitro tests for acute skin irritation, Results and evaluation by the Management Team, Toxicol. in Vitro 15, 57–93.
Lithuanian: M. and Botham, P. (2001), A prevalidation study on in vitro tests for acute skin irritation, Results and evaluation by the Management Team, Toxicol. in Vitro 15, 57–93.
Maltese: M. u Botham, P. (2001), A prevalidation study on in vitro tests for acute skin irritation, Results and evaluation by the Management Team, Toxicol. in Vitro 15, 57–93.
English: Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. and Zuang, V. (2007), The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals, ATLA 35, 603-619.
French: Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. et Zuang, V. (2007), The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals, ATLA 35, 603-619.
Portuguese: Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I., Zuang, V. (2007). The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals. ATLA, 35, 603-619.
Swedish: Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. och Zuang, V. (2007), The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals, ATLA 35, 603–619.
Finnish: Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. ja Zuang, V. (2007). The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals. ATLA 35, s. 603–619.
Czech: Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. and Zuang, V. (2007), The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals, ATLA 35, 603–619.
Slovak: Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. and Zuang, V. (2007), The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals, ATLA 35, 603 – 619.
Polish: Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. and Zuang, V. (2007), The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals, ATLA 35, 603–619.
Slovenian: Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. and Zuang, V. (2007), The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals, ATLA 35, 603–619.
Estonian: Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. and Zuang, V. (2007), The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals, ATLA 35, 603–619.
Latvian: Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. and Zuang, V. (2007), The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals, ATLA 35, 603-619.
Lithuanian: Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. and Zuang, V. (2007), The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals, ATLA 35, 603–619.
Maltese: Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. u Zuang, V. (2007), The ECVAM international validation study on in vitro tests for acute skin irritation: selection of test chemicals, ATLA 35, 603–619.
English: OECD (2010), Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing.
French: OCDE (2010), Document explicatif accompagnant le projet de Ligne directrice de l’OCDE sur l’essai d’irritation cutanée in vitro.
Spanish: OCDE (2010), Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing.
Italian: OCSE (2010), Explanatory background document to the OCSE draft Test Guideline on in vitro skin irritation testing. OCSE Series on Testing and Assessment, No.
Portuguese: OCDE (2010). Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing.
Dutch: OECD (2010), Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing. OECD Series on Testing and Assessment, No.
Swedish: OECD (2010), Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing. OECD Series on Testing and Assessment, No.
Finnish: OECD (2010). Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing.
Greek: OECD (2010), Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing. OECD Series on Testing and Assessment, No.
Czech: OECD (2010), Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing. OECD Series on Testing and Assessment, No.
Slovak: OECD (2010), Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing.
Polish: OECD (2010), Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing. OECD Series on Testing and Assessment, No.
Hungarian: OECD (2010), Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing. OECD Series on Testing and Assessment, No.
Slovenian: OECD (2010), Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing. OECD Series on Testing and Assessment, No.
Estonian: OECD (2010), Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing. OECD Series on Testing and Assessment, No.
Latvian: OECD (2010), Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing. OECD Series on Testing and Assessment, No.
Lithuanian: OECD (2010), Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing. OECD Series on Testing and Assessment, No.
English: State of the art review of mechanisms and models, Toxicol. in Vitro 18, 231-243.
French: Toxicol. in Vitro 18, 231-243.
Portuguese: Toxicol. in Vitro, 18, 231-243.
Swedish: State of the art review of mechanisms and models, Toxicol. in Vitro 18, 231–243.
Finnish: Toxicol. in Vitro 18, s. 231–243.
Czech: State of the art review of mechanisms and models, Toxicol. in Vitro 18, 231–243.
Slovak: State of the art review of mechanisms and models, Toxicol. in Vitro 18, 231 – 243.
Polish: State of the art. review of mechanisms and models, Toxicol. in Vitro 18, 231–243.
Slovenian: State of the art review of mechanisms and models, Toxicol. in Vitro 18, 231–243.
Estonian: State of the art review of mechanisms and models, Toxicol. in Vitro 18, 231–243.
Lithuanian: State of the art review of mechanisms and models, Toxicol. in Vitro 18, 231–243.
Maltese: State of the art review of mechanisms and models, Toxicol. in Vitro 18, 231–243.